{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:03:35Z","timestamp":1789689815457,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s12308-022-00526-3","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T04:39:24Z","timestamp":1674189564000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute mast cell leukemia without KIT D816V mutation and lack of CD2 and CD25\u2014a case report of rare entity"],"prefix":"10.1007","volume":"16","author":[{"given":"Eliza","family":"Zaremba-Pataj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8691-4310","authenticated-orcid":false,"given":"El\u017cbieta","family":"Patkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7647-3336","authenticated-orcid":false,"given":"Agnieszka","family":"Krzywdzi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-3422","authenticated-orcid":false,"given":"Anna","family":"Szumera-Cie\u0107kiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3997-3948","authenticated-orcid":false,"given":"Justyna","family":"Chlebowska-Tuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"526_CR1","first-page":"86","volume":"6","author":"K Lewandowski","year":"2020","unstructured":"Lewandowski K (2020) Mastocytosis. Oncology in Clinical. Practice 6:86\u201398","journal-title":"Practice"},{"key":"526_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1182\/blood-2012-07-442400","volume":"121","author":"S Georgin-Lavialle","year":"2013","unstructured":"Georgin-Lavialle S, Lhermitte L, Dubreuil P et al (2013) Mast cell leukemia. Blood 121:1285\u20131295. https:\/\/doi.org\/10.1182\/blood-2012-07-442400","journal-title":"Blood"},{"key":"526_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaip.2018.09.024","volume":"7","author":"P Valent","year":"2019","unstructured":"Valent P, Oude Elberink JNG, Gorska A et al (2019) The Data Registry of the European Competence Network on Mastocytosis (ECNM): set up, projects, and perspectives. J Allergy Clin Immunol Pract 7:81\u201387. https:\/\/doi.org\/10.1016\/j.jaip.2018.09.024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"526_CR4","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","volume":"129","author":"P Valent","year":"2017","unstructured":"Valent P, Akin C, Metcalfe DD (2017) Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood 129:1420\u20131427. https:\/\/doi.org\/10.1182\/blood-2016-09-731893","journal-title":"Blood"},{"key":"526_CR5","unstructured":"Horny HP, Akin C, Arber DA, Peterson LC,Tefferi A (2016) Mastocytosis. In: Swerdlow E et al, (ed) World Health Organization (WHO) Classification of Tumours. Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. IARC Press, Lyon, France."},{"key":"526_CR6","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-16-2234","volume":"77","author":"P Valent","year":"2017","unstructured":"Valent P, Akin C, Hartmann K et al (2017) Advances in the classification and treatment of mastocytosis: current status and outlook toward the future. Cancer Res 77:1261\u20131270. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2234","journal-title":"Cancer Res"},{"key":"526_CR7","unstructured":"Hans-Peter H, Sotlar K, Metzgeroth G, Reiter A,Valent P (2018) Mastocytosis and the updated WHO classification (2016, 2017): what is really new? Ann Hematol Oncol. 5(2):1194."},{"key":"526_CR8","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/ajh.24553","volume":"91","author":"A Pardanani","year":"2016","unstructured":"Pardanani A (2016) Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management. Am J Hematol 91:1146\u20131159. https:\/\/doi.org\/10.1002\/ajh.24553","journal-title":"Am J Hematol"},{"key":"526_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/leu.2015.4","volume":"29","author":"M Jawhar","year":"2015","unstructured":"Jawhar M, Schwaab J, Schnittger S et al (2015) Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event. Leukemia 29:1115\u20131122. https:\/\/doi.org\/10.1038\/leu.2015.4","journal-title":"Leukemia"},{"issue":"7","key":"526_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/dc.23965","volume":"46","author":"M Costopoulos","year":"2018","unstructured":"Costopoulos M, Uzunov M, Bories D et al (2018) Acute mast cell leukemia: a rare but highly aggressive hematopoietic neoplasm. Diagn Cytopathol 46(7):639\u2013641","journal-title":"Diagn Cytopathol"},{"key":"526_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.iac.2014.01.005","volume":"34","author":"HP Horny","year":"2014","unstructured":"Horny HP, Sotlar K, Valent P (2014) Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells. Immunol Allergy Clin North Am 34:315\u2013321. https:\/\/doi.org\/10.1016\/j.iac.2014.01.005","journal-title":"Immunol Allergy Clin North Am"},{"key":"526_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jaci.2009.10.020","volume":"125","author":"C Teodosio","year":"2010","unstructured":"Teodosio C, Garcia-Montero AC, Jara-Acevedo M et al (2010) Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol 125:719\u2013726. https:\/\/doi.org\/10.1016\/j.jaci.2009.10.020","journal-title":"J Allergy Clin Immunol"},{"key":"526_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1189\/jlb.5RU0614-296R","volume":"97","author":"C Teodosio","year":"2015","unstructured":"Teodosio C, Mayado A, Sanchez-Munoz L et al (2015) The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis. J Leukoc Biol 97:49\u201359. https:\/\/doi.org\/10.1189\/jlb.5RU0614-296R","journal-title":"J Leukoc Biol"},{"key":"526_CR14","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/ccr3.2208","volume":"7","author":"A Bosch-Vilaseca","year":"2019","unstructured":"Bosch-Vilaseca A, Monter-Rovira A, Cisa-Wieczorek S et al (2019) Ultrastructural, cytogenetic, and molecular findings in mast cell leukemia: case report. Clin Case Rep 7:1395\u20131398. https:\/\/doi.org\/10.1002\/ccr3.2208","journal-title":"Clin Case Rep"},{"key":"526_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13000-018-0691-2","volume":"13","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Nong L, Liang L, Wang W, Li T (2018) De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child. Diagn Pathol 13:14. https:\/\/doi.org\/10.1186\/s13000-018-0691-2","journal-title":"Diagn Pathol"},{"key":"526_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/ajh.26118","volume":"96","author":"A Pardanani","year":"2021","unstructured":"Pardanani A (2021) Systemic mastocytosis in adults: 2021 update on diagnosis, risk stratification and management. Am J Hematol 96:508\u2013525. https:\/\/doi.org\/10.1002\/ajh.26118","journal-title":"Am J Hematol"},{"key":"526_CR17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1182\/blood-2004-12-4617","volume":"106","author":"JD Growney","year":"2005","unstructured":"Growney JD, Clark JJ, Adelsperger J et al (2005) Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412. Blood 106:721\u2013724. https:\/\/doi.org\/10.1182\/blood-2004-12-4617","journal-title":"Blood"},{"key":"526_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007258","volume":"4","author":"P Dubreuil","year":"2009","unstructured":"Dubreuil P, Letard S, Ciufolini M et al (2009) Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT. PLoS ONE 4:e7258. https:\/\/doi.org\/10.1371\/journal.pone.0007258","journal-title":"PLoS ONE"},{"key":"526_CR19","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s00432-015-1988-0","volume":"141","author":"A Hochhaus","year":"2015","unstructured":"Hochhaus A, Baccarani M, Giles FJ et al (2015) Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study. J Cancer Res Clin Oncol 141:2047\u20132060. https:\/\/doi.org\/10.1007\/s00432-015-1988-0","journal-title":"J Cancer Res Clin Oncol"},{"key":"526_CR20","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-08-0366","volume":"14","author":"S Verstovsek","year":"2008","unstructured":"Verstovsek S, Tefferi A, Cortes J et al (2008) Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis. Clin Cancer Res 14:3906\u20133915. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0366","journal-title":"Clin Cancer Res"},{"key":"526_CR21","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","volume":"374","author":"J Gotlib","year":"2016","unstructured":"Gotlib J, Kluin-Nelemans HC, George TI et al (2016) Efficacy and safety of midostaurin in advanced systemic mastocytosis. N Engl J Med 374:2530\u20132541. https:\/\/doi.org\/10.1056\/NEJMoa1513098","journal-title":"N Engl J Med"},{"key":"526_CR22","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1200\/JCO.2014.55.2018","volume":"32","author":"C Ustun","year":"2014","unstructured":"Ustun C, Reiter A, Scott BL et al (2014) Hematopoietic stem-cell transplantation for advanced systemic mastocytosis. J Clin Oncol 32:3264\u20133274. https:\/\/doi.org\/10.1200\/JCO.2014.55.2018","journal-title":"J Clin Oncol"},{"key":"526_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2014.09.010","volume":"39","author":"P Valent","year":"2015","unstructured":"Valent P, Sotlar K, Sperr WR et al (2015) Chronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical features. Leuk Res 39:1\u20135. https:\/\/doi.org\/10.1016\/j.leukres.2014.09.010","journal-title":"Leuk Res"},{"key":"526_CR24","doi-asserted-by":"publisher","first-page":"1805270","DOI":"10.1155\/2019\/1805270","volume":"2019","author":"DS Soliman","year":"2019","unstructured":"Soliman DS, Al-Sabbagh A, Ibrahim F et al (2019) Highly aggressive CD4-positive mast cell leukaemia (leukaemic variant) associated with isolated trisomy 19 and hemophagocytosis by neoplastic mast cells: a case report with challenging experience and review. Case Rep Hematol 2019:1805270. https:\/\/doi.org\/10.1155\/2019\/1805270","journal-title":"Case Rep Hematol"},{"issue":"2","key":"526_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3343\/alm.2013.33.2.125","volume":"33","author":"MH Bae","year":"2013","unstructured":"Bae MH, Kim HK, Park CJ et al (2013) A case of systemic mastocytosis associated with acute myeloid leukemia terminating as aleukemic mast cell leukemia after allogeneic hematopoietic stem cell transplantation. Ann Lab Med 33(2):125\u2013129","journal-title":"Ann Lab Med"},{"key":"526_CR26","doi-asserted-by":"publisher","first-page":"3890361","DOI":"10.1155\/2018\/3890361","volume":"2018","author":"M Lopes","year":"2018","unstructured":"Lopes M, Teixeira MDA, Casais C et al (2018) KIT D816V positive acute mast cell leukemia associated with normal karyotype acute myeloid leukemia. Case Rep Hematol 2018:3890361. https:\/\/doi.org\/10.1155\/2018\/3890361","journal-title":"Case Rep Hematol"},{"key":"526_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.humpath.2017.03.014","volume":"67","author":"RC Wang","year":"2017","unstructured":"Wang RC, Ward D, Dunn P, Chang CC (2017) Acute mast cell leukemia associated with t(4;5)(q21;q33). Hum Pathol 67:198\u2013204. https:\/\/doi.org\/10.1016\/j.humpath.2017.03.014","journal-title":"Hum Pathol"},{"key":"526_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2020.100230","volume":"14","author":"GM Galura","year":"2020","unstructured":"Galura GM, Cherukuri SV, Hakim N, Gaur S, Orazi A (2020) Acute aleukemic mast cell leukemia: report of a case and review of the literature. Leuk Res Rep 14:100230. https:\/\/doi.org\/10.1016\/j.lrr.2020.100230","journal-title":"Leuk Res Rep"},{"key":"526_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2147\/CPAA.S206615","volume":"11","author":"JA Gilreath","year":"2019","unstructured":"Gilreath JA, Tchertanov L, Deininger MW (2019) Novel approaches to treating advanced systemic mastocytosis. Clin Pharmacol 11:77\u201392. https:\/\/doi.org\/10.2147\/CPAA.S206615","journal-title":"Clin Pharmacol"},{"issue":"6","key":"526_CR30","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3324\/haematol.2017.163964","volume":"102","author":"M Jawhar","year":"2017","unstructured":"Jawhar M, Schwaab J, Meggendorfer M et al (2017) The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm. Haematologica 102(6):1035\u20131043","journal-title":"Haematologica"},{"key":"526_CR31","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/leu.2015.24","volume":"29","author":"M Arock","year":"2015","unstructured":"Arock M, Sotlar K, Akin C et al (2015) KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis. Leukemia 29:1223\u20131232. https:\/\/doi.org\/10.1038\/leu.2015.24","journal-title":"Leukemia"},{"issue":"21","key":"526_CR32","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.18632\/oncotarget.4213","volume":"6","author":"A Chatterjee","year":"2015","unstructured":"Chatterjee A, Ghosh J, Kapur R (2015) Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder. Oncotarget 6(21):18250\u201318264","journal-title":"Oncotarget"},{"key":"526_CR33","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/all.12409","volume":"69","author":"G Hoermann","year":"2014","unstructured":"Hoermann G, Gleixner KV, Dinu GE et al (2014) The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease. Allergy 69:810\u2013813. https:\/\/doi.org\/10.1111\/all.12409","journal-title":"Allergy"},{"key":"526_CR34","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3324\/haematol.2019.217950","volume":"105","author":"G Greiner","year":"2020","unstructured":"Greiner G, Gurbisz M, Ratzinger F et al (2020) Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis. Haematologica 105:366\u2013374. https:\/\/doi.org\/10.3324\/haematol.2019.217950","journal-title":"Haematologica"},{"key":"526_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000646","volume":"5","author":"P Valent","year":"2021","unstructured":"Valent P, Akin C, Hartmann K et al (2021) Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal. Hemasphere 5:e646. https:\/\/doi.org\/10.1097\/HS9.0000000000000646","journal-title":"Hemasphere"},{"key":"526_CR36","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1002\/1521-4141(200111)31:11<3298::aid-immu3298>3.0.co;2-u","volume":"31","author":"MR Woolhiser","year":"2001","unstructured":"Woolhiser MR, Okayama Y, Gilfillan AM, Metcalfe DD (2001) IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma. Eur J Immunol 31:3298\u20133307. https:\/\/doi.org\/10.1002\/1521-4141(200111)31:11%3c3298::aid-immu3298%3e3.0.co;2-u","journal-title":"Eur J Immunol"},{"key":"526_CR37","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood.2019000932","volume":"135","author":"A Reiter","year":"2020","unstructured":"Reiter A, George TI, Gotlib J (2020) New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis. Blood 135:1365\u20131376. https:\/\/doi.org\/10.1182\/blood.2019000932","journal-title":"Blood"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-022-00526-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-022-00526-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-022-00526-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T01:05:45Z","timestamp":1705712745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-022-00526-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1007\/s12308-022-00526-3","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]},"assertion":[{"value":"4 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors gave consent for the manuscript publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}